Trademark: 90502530
Word
ALENURA
Status
Pending
Status Code
733
Status Date
Thursday, November 30, 2023
Serial Number
90502530
Mark Type
4000
Filing Date
Monday, February 1, 2021
Published for Opposition
Tuesday, October 5, 2021

Trademark Owner History
Urigen Pharmaceuticals Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of urological ailments; Pharmaceutical preparations for the treatment of interstitial cystitis and bladder pain syndrome (IC/BPS)

Trademark Events
Dec 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2023
Sou Extension 4 Granted
Nov 30, 2023
Sou Extension 4 Filed
Nov 30, 2023
Sou Teas Extension Received
Jun 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2023
Corrected Noa E-Mailed
Jun 29, 2023
Sou Extension 3 Granted
May 30, 2023
Sou Extension 3 Filed
Jun 29, 2023
Divisional Processing Complete
May 30, 2023
Divisional Request Received
Jun 20, 2023
Case Assigned To Intent To Use Paralegal
May 30, 2023
Teas Request To Divide Received
May 30, 2023
Sou Teas Extension Received
Dec 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2022
Sou Extension 2 Granted
Nov 30, 2022
Sou Extension 2 Filed
Nov 30, 2022
Sou Teas Extension Received
May 31, 2022
Notice Of Approval Of Extension Request E-Mailed
May 27, 2022
Sou Extension 1 Granted
May 27, 2022
Sou Extension 1 Filed
May 27, 2022
Sou Teas Extension Received
Nov 30, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 5, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 5, 2021
Published For Opposition
Sep 15, 2021
Notification Of Notice Of Publication E-Mailed
Aug 27, 2021
Approved For Pub - Principal Register
Aug 20, 2021
Assigned To Examiner
May 4, 2021
New Application Office Supplied Data Entered
Feb 4, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24